Unknown

Dataset Information

0

Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains.


ABSTRACT: Bromodomain-containing proteins are considered atypical kinases, but their potential to interact with kinase inhibitors is unknown. Dinaciclib is a potent inhibitor of cyclin-dependent kinases (CDKs), which recently advanced to Phase III clinical trials for the treatment of leukemia. We determined the crystal structure of dinaciclib in complex with CDK2 at 1.7 Å resolution, revealing an elaborate network of binding interactions in the ATP site, which explains the extraordinary potency and selectivity of this inhibitor. Remarkably, dinaciclib also interacted with the acetyl-lysine recognition site of the bromodomain testis-specific protein BRDT, a member of the BET family of bromodomains. The binding mode of dinaciclib to BRDT at 2.0 Å resolution suggests that general kinase inhibitors ("hinge binders") possess a previously unrecognized potential to act as protein-protein inhibitors of bromodomains. The findings may provide a new structural framework for the design of next-generation bromodomain inhibitors using the vast chemical space of kinase inhibitors.

SUBMITTER: Martin MP 

PROVIDER: S-EPMC3846258 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains.

Martin Mathew P MP   Olesen Sanne H SH   Georg Gunda I GI   Schönbrunn Ernst E  

ACS chemical biology 20130910 11


Bromodomain-containing proteins are considered atypical kinases, but their potential to interact with kinase inhibitors is unknown. Dinaciclib is a potent inhibitor of cyclin-dependent kinases (CDKs), which recently advanced to Phase III clinical trials for the treatment of leukemia. We determined the crystal structure of dinaciclib in complex with CDK2 at 1.7 Å resolution, revealing an elaborate network of binding interactions in the ATP site, which explains the extraordinary potency and select  ...[more]

Similar Datasets

| S-EPMC4032195 | biostudies-literature
| S-EPMC5312924 | biostudies-literature
| S-EPMC7595101 | biostudies-literature
| S-EPMC9732436 | biostudies-literature
| S-EPMC3601112 | biostudies-literature
| S-EPMC4747838 | biostudies-literature
| S-EPMC3784060 | biostudies-literature
| S-EPMC7034242 | biostudies-literature
| S-EPMC3349821 | biostudies-literature
| S-EPMC4007794 | biostudies-other